Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127247571 | 12724757 | 1 | I | 20160726 | 20160826 | 20160908 | 20160908 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-071214 | BRISTOL MYERS SQUIBB | 12.77 | YR | F | Y | 0.00000 | 20160908 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127247571 | 12724757 | 1 | PS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 89 MG, BID | U | 20457 | 89 | MG | POWDER FOR INJECTION | BID | |||||
| 127247571 | 12724757 | 2 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 0.56 G, QD | 2 | G | U | 0 | .56 | G | QD | ||||
| 127247571 | 12724757 | 3 | C | FRAGMINE | DALTEPARIN SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 127247571 | 12724757 | 4 | C | ZOPHREN /00955301/ | ONDANSETRON | 1 | Unknown | U | 0 | ||||||||||
| 127247571 | 12724757 | 5 | C | METHYLENE BLUE. | METHYLENE BLUE | 1 | Unknown | U | 0 | ||||||||||
| 127247571 | 12724757 | 6 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | Unknown | U | 0 | ||||||||||
| 127247571 | 12724757 | 7 | C | ELUDRIL /00133002/ | 2 | Unknown | U | 0 | |||||||||||
| 127247571 | 12724757 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | U | 0 | ||||||||||
| 127247571 | 12724757 | 9 | C | RIVOTRIL | CLONAZEPAM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127247571 | 12724757 | 1 | Osteosarcoma |
| 127247571 | 12724757 | 2 | Osteosarcoma |
| 127247571 | 12724757 | 3 | Product used for unknown indication |
| 127247571 | 12724757 | 4 | Product used for unknown indication |
| 127247571 | 12724757 | 5 | Product used for unknown indication |
| 127247571 | 12724757 | 6 | Product used for unknown indication |
| 127247571 | 12724757 | 7 | Product used for unknown indication |
| 127247571 | 12724757 | 8 | Product used for unknown indication |
| 127247571 | 12724757 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127247571 | 12724757 | HO |
| 127247571 | 12724757 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127247571 | 12724757 | Epistaxis | |
| 127247571 | 12724757 | Febrile bone marrow aplasia | |
| 127247571 | 12724757 | Product use issue | |
| 127247571 | 12724757 | Renal tubular disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127247571 | 12724757 | 1 | 20160722 | 0 | ||
| 127247571 | 12724757 | 2 | 20160720 | 0 |